Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,283.50 JPY | +0.35% |
|
-0.50% | -27.18% |
Jun. 12 | Trump throws curveball at Japan tea giant's US expansion swing | RE |
Apr. 28 | Kikkoman to Buy Back Up to 20 Billion Yen of Shares | MT |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.48 | 6.52 | 6.62 | 6.77 | 7.06 | |||||
Return on Total Capital | 8.08 | 8.06 | 8.18 | 8.27 | 8.49 | |||||
Return On Equity % | 9.85 | 10.7 | 11.62 | 11.32 | 12.43 | |||||
Return on Common Equity | 9.89 | 10.73 | 11.68 | 11.38 | 12.52 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 38.76 | 35.1 | 34.63 | 33.03 | 34.61 | |||||
SG&A Margin | 30.26 | 22.59 | 22.05 | 21.28 | 21.27 | |||||
EBITDA Margin % | 11.87 | 14.19 | 13.54 | 12.95 | 14.18 | |||||
EBITA Margin % | 8.29 | 9.81 | 9.66 | 9.35 | 10.55 | |||||
EBIT Margin % | 8.29 | 9.81 | 9.66 | 9.35 | 10.55 | |||||
Income From Continuing Operations Margin % | 5.76 | 7.2 | 7.62 | 7.14 | 8.61 | |||||
Net Income Margin % | 5.68 | 7.09 | 7.53 | 7.07 | 8.54 | |||||
Net Avail. For Common Margin % | 5.68 | 7.09 | 7.53 | 7.07 | 8.54 | |||||
Normalized Net Income Margin | 5.06 | 5.93 | 5.32 | 5.32 | 6.16 | |||||
Levered Free Cash Flow Margin | 2.78 | 7.07 | 3.39 | 2.02 | 0.29 | |||||
Unlevered Free Cash Flow Margin | 2.85 | 7.2 | 3.48 | 2.12 | 0.43 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.25 | 1.06 | 1.1 | 1.16 | 1.07 | |||||
Fixed Assets Turnover | 3.44 | 2.95 | 3.34 | 3.63 | 3.38 | |||||
Receivables Turnover (Average Receivables) | 7.81 | 7.17 | 7.83 | 8.57 | 8.32 | |||||
Inventory Turnover (Average Inventory) | 4.79 | 4.6 | 4.63 | 4.74 | 4.62 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.58 | 2.65 | 2.89 | 2.85 | 3.6 | |||||
Quick Ratio | 1.46 | 1.63 | 1.79 | 1.77 | 2.14 | |||||
Operating Cash Flow to Current Liabilities | 0.64 | 0.79 | 0.63 | 0.6 | 0.85 | |||||
Days Sales Outstanding (Average Receivables) | 46.84 | 50.89 | 46.64 | 42.6 | 44 | |||||
Days Outstanding Inventory (Average Inventory) | 76.39 | 79.38 | 78.81 | 77.02 | 79.28 | |||||
Average Days Payable Outstanding | 28.99 | 47.01 | 56.29 | 52.04 | 53.19 | |||||
Cash Conversion Cycle (Average Days) | 94.24 | 83.26 | 69.16 | 67.58 | 70.09 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 12.73 | 13.29 | 11.94 | 12.23 | 12.02 | |||||
Total Debt / Total Capital | 11.29 | 11.73 | 10.67 | 10.89 | 10.73 | |||||
LT Debt/Equity | 9.94 | 10.44 | 9.52 | 6.9 | 9.87 | |||||
Long-Term Debt / Total Capital | 8.81 | 9.22 | 8.5 | 6.15 | 8.81 | |||||
Total Liabilities / Total Assets | 28.29 | 28.5 | 27.66 | 26.38 | 25.4 | |||||
EBIT / Interest Expense | 83.68 | 46.91 | 67.7 | 58.18 | 46.78 | |||||
EBITDA / Interest Expense | 119.86 | 67.84 | 94.87 | 80.53 | 62.9 | |||||
(EBITDA - Capex) / Interest Expense | 66.41 | 50.73 | 69.5 | 54.81 | 42.97 | |||||
Total Debt / EBITDA | 0.64 | 0.67 | 0.62 | 0.64 | 0.64 | |||||
Net Debt / EBITDA | 0.09 | -0.22 | -0.51 | -0.6 | -0.63 | |||||
Total Debt / (EBITDA - Capex) | 1.15 | 0.89 | 0.85 | 0.93 | 0.94 | |||||
Net Debt / (EBITDA - Capex) | 0.17 | -0.3 | -0.7 | -0.89 | -0.93 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.32 | -6.23 | 17.53 | 19.84 | 6.78 | |||||
Gross Profit, 1 Yr. Growth % | 3.34 | -15.09 | 15.95 | 14.31 | 11.88 | |||||
EBITDA, 1 Yr. Growth % | 9.45 | 12.1 | 12.16 | 14.6 | 16.96 | |||||
EBITA, 1 Yr. Growth % | 3.38 | 11.02 | 15.74 | 16.03 | 20.4 | |||||
EBIT, 1 Yr. Growth % | 3.38 | 11.02 | 15.74 | 16.03 | 20.4 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 2.28 | 17.1 | 24.42 | 12.34 | 28.73 | |||||
Net Income, 1 Yr. Growth % | 2.32 | 17.16 | 24.85 | 12.42 | 29.06 | |||||
Normalized Net Income, 1 Yr. Growth % | 12.84 | 9.85 | 5.34 | 19.78 | 23.76 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 2.32 | 17.16 | 25.03 | 12.53 | 29.6 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.08 | 4.38 | 10.91 | 8.16 | 11.66 | |||||
Inventory, 1 Yr. Growth % | 3.59 | 3.5 | 31.09 | 11.51 | 2.98 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 20.81 | 0.1 | 7.01 | 13.46 | 16.04 | |||||
Total Assets, 1 Yr. Growth % | 6.96 | 13.21 | 14.72 | 12.59 | 17.92 | |||||
Tangible Book Value, 1 Yr. Growth % | 3.19 | 13.21 | 16.84 | 15.17 | 20.43 | |||||
Common Equity, 1 Yr. Growth % | 2.64 | 13.1 | 16.12 | 14.73 | 19.69 | |||||
Cash From Operations, 1 Yr. Growth % | 7.11 | 44.16 | -8.88 | 13.64 | 36.51 | |||||
Capital Expenditures, 1 Yr. Growth % | -6.71 | -36.62 | 18.95 | 36.89 | 16.05 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 166.9 | 138.2 | -43.62 | -28.73 | -84.7 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 168.34 | 137.33 | -43.19 | -27.09 | -78.32 | |||||
Dividend Per Share, 1 Yr. Growth % | 2.44 | 7.14 | 35.56 | 11.48 | 52.94 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 4.32 | -1.57 | 4.98 | 18.68 | 13.12 | |||||
Gross Profit, 2 Yr. CAGR % | 3.31 | -6.32 | -0.78 | 15.13 | 13.09 | |||||
EBITDA, 2 Yr. CAGR % | 5.82 | 10.76 | 12.13 | 13.37 | 15.77 | |||||
EBITA, 2 Yr. CAGR % | 3.13 | 7.14 | 13.36 | 15.89 | 18.2 | |||||
EBIT, 2 Yr. CAGR % | 3.13 | 7.14 | 13.36 | 15.89 | 18.2 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 5.73 | 9.44 | 20.7 | 18.23 | 20.26 | |||||
Net Income, 2 Yr. CAGR % | 5.61 | 9.49 | 20.95 | 18.47 | 20.45 | |||||
Normalized Net Income, 2 Yr. CAGR % | 0.42 | 11.34 | 7.57 | 12.33 | 21.75 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 5.82 | 9.49 | 21.03 | 18.62 | 20.77 | |||||
Accounts Receivable, 2 Yr. CAGR % | 1.71 | 2.12 | 7.6 | 9.53 | 9.89 | |||||
Inventory, 2 Yr. CAGR % | 6.59 | 3.54 | 16.48 | 20.91 | 7.16 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 16.35 | 9.97 | 3.5 | 10.19 | 14.74 | |||||
Total Assets, 2 Yr. CAGR % | 5.66 | 10.04 | 13.96 | 13.65 | 15.22 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.27 | 8.09 | 15.01 | 16 | 17.77 | |||||
Common Equity, 2 Yr. CAGR % | 4.8 | 7.74 | 14.6 | 15.42 | 17.18 | |||||
Cash From Operations, 2 Yr. CAGR % | 2.63 | 24.26 | 14.62 | 1.76 | 24.55 | |||||
Capital Expenditures, 2 Yr. CAGR % | 23.01 | -23.11 | -13.17 | 27.61 | 26.04 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -20.51 | 152.15 | 15.88 | -36.61 | -66.98 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -19.99 | 152.36 | 16.11 | -35.64 | -60.24 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.14 | 4.76 | 20.51 | 22.93 | 30.57 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.23 | 0.68 | 4.42 | 9.72 | 14.57 | |||||
Gross Profit, 3 Yr. CAGR % | 4.36 | -3.23 | 0.58 | 4.02 | 14.04 | |||||
EBITDA, 3 Yr. CAGR % | 7.17 | 7.87 | 11.23 | 12.95 | 14.56 | |||||
EBITA, 3 Yr. CAGR % | 5.74 | 5.7 | 9.93 | 14.24 | 17.37 | |||||
EBIT, 3 Yr. CAGR % | 5.74 | 5.7 | 9.93 | 14.24 | 17.37 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 4.21 | 9.39 | 14.22 | 17.85 | 21.63 | |||||
Net Income, 3 Yr. CAGR % | 3.76 | 9.33 | 14.39 | 18.03 | 21.9 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.92 | 3.47 | 9.3 | 11.5 | 16.02 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.97 | 9.48 | 14.44 | 18.13 | 22.17 | |||||
Accounts Receivable, 3 Yr. CAGR % | 3.26 | 2.59 | 4.97 | 7.78 | 10.23 | |||||
Inventory, 3 Yr. CAGR % | 7.1 | 5.55 | 12.02 | 14.8 | 14.61 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.92 | 10.66 | 8.97 | 6.72 | 12.1 | |||||
Total Assets, 3 Yr. CAGR % | 2.35 | 8.12 | 11.58 | 13.5 | 15.06 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.85 | 7.86 | 10.93 | 15.06 | 17.46 | |||||
Common Equity, 3 Yr. CAGR % | 4.31 | 7.49 | 10.47 | 14.65 | 16.83 | |||||
Cash From Operations, 3 Yr. CAGR % | 14.91 | 14.94 | 12.06 | 14.29 | 12.23 | |||||
Capital Expenditures, 3 Yr. CAGR % | 31.24 | -1.39 | -11.07 | 1.06 | 23.63 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 16.04 | 14.61 | 53.04 | -1.45 | -60.53 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 14.75 | 14.96 | 53.51 | -0.57 | -55.22 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.3 | 9.79 | 14.16 | 17.42 | 32.21 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.76 | 1.48 | 5.13 | 7.52 | 7.82 | |||||
Gross Profit, 5 Yr. CAGR % | 4.47 | -0.75 | 2.27 | 3.74 | 5.41 | |||||
EBITDA, 5 Yr. CAGR % | 7.76 | 6.96 | 9.13 | 10.04 | 13.02 | |||||
EBITA, 5 Yr. CAGR % | 8.88 | 5.75 | 8.72 | 9.66 | 13.16 | |||||
EBIT, 5 Yr. CAGR % | 8.88 | 5.75 | 8.72 | 9.66 | 13.16 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.75 | 9.41 | 10.52 | 12.84 | 16.6 | |||||
Net Income, 5 Yr. CAGR % | 11.57 | 9.31 | 10.32 | 12.9 | 16.78 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.45 | 4.49 | 6.58 | 6.93 | 14.12 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.12 | 9.59 | 10.48 | 13.04 | 16.93 | |||||
Accounts Receivable, 5 Yr. CAGR % | 3.81 | 3.96 | 4.98 | 5.31 | 6.91 | |||||
Inventory, 5 Yr. CAGR % | 4.46 | 5.42 | 10.76 | 11.45 | 10.05 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 7.32 | 7.29 | 8.47 | 10.47 | 11.25 | |||||
Total Assets, 5 Yr. CAGR % | 0.45 | 3.7 | 6.85 | 10.3 | 13.02 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.22 | 7.55 | 8.8 | 11.04 | 13.62 | |||||
Common Equity, 5 Yr. CAGR % | 2.87 | 6.62 | 8.31 | 10.6 | 13.11 | |||||
Cash From Operations, 5 Yr. CAGR % | 4.61 | 8.71 | 14.79 | 9.48 | 16.89 | |||||
Capital Expenditures, 5 Yr. CAGR % | 16.86 | 3.85 | 11.25 | 9.32 | 2.24 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 9.41 | 2.27 | 15.98 | -9.57 | -17.13 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 8.1 | 2.16 | 15.29 | -8.85 | -10.58 | |||||
Dividend Per Share, 5 Yr. CAGR % | 11.84 | 7.06 | 12.4 | 14.87 | 20.46 |
- Stock Market
- Equities
- 2801 Stock
- Financials Kikkoman Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions